- Home
- Healthcare professionals
- ACE Technology Guidances
- Drug Guidance
- Ciclosporin 0.1% eye drops for treating severe vernal keratoconjunctivitis
Drug guidance
Ciclosporin 0.1% eye drops for treating severe vernal keratoconjunctivitis
Eye
19 December 2022
Published on 19 Dec 2022
Last Updated on 19 Dec 2022
Guidance Recommendations
The Ministry of Health's Drug Advisory Committee has not recommended listing ciclosporin (CsA) 0.1% eye drops on the MOH List of Subsidised Drugs for treating severe vernal keratoconjunctivitis due to the uncertain clinical and cost effectiveness compared with current standard of care.